Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Myeloproliferative Disorders, Myeloproliferative Disorders (MPD)
Both
Myeloproliferative Disorders, Myeloproliferative Disorders (MPD)
Trial Information
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
Inclusion Criteria:
Any patient who carries a diagnosis of a myeloproliferative disorder(MPD).
Exclusion Criteria:Any patient who is not willing to give consent.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Jason Robert Gotlib
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
SU-07092009-3060
NCT ID:
NCT01144780
Start Date:
September 2009
Completion Date:
August 2011
Related Keywords:
- Myeloproliferative Disorders
- Myeloproliferative Disorders (MPD)
- Myeloproliferative Disorders
Name | Location |
|---|---|
| Stanford University School of Medicine | Stanford, California 94305-5317 |
